Emisphere Technologies
Roseland · Founded 1986
About Emisphere Technologies
Emisphere is a pharmaceutical company utilizing its proprietary Eligen Technology to create new oral formulations of therapeutic agents. Emisphere currently has a number of product candidates in its pipeline at varying stages. There are multiple product candidates in clinical development as well as several pre-clinical development/research programs. The Company considers specific criteria when deciding whether to devote resources to a development program. The markets that Emisphere seeks to enter for a potential product should be substantial. The product candidate should meet a clear unmet medical or market need and the product profile should clearly differentiate Emisphere's products. The Company also considers the level of product development effort in relation to a reasonable return on investment within an acceptable timeframe.
Company Facts
- Founded: 1986
- Legal name: EMISPHERE TECHNOLOGIES INC
- Operating status: Acquired
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $42.5M
- Funding stage: M&A
- Last round: Post-IPO Debt (Aug 2014)
- Website: emisphere.com
- Phone: 9735328017
Social Profiles
Canonical: https://fsome.com/organization/emisphere-technologies-8388972 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.